Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
204
-
Total 13F shares, excl. options
-
38.6M
-
Shares change
-
+1.1M
-
Total reported value, excl. options
-
$3.74B
-
Value change
-
+$110M
-
Put/Call ratio
-
1.43
-
Number of buys
-
116
-
Number of sells
-
-82
-
Price
-
$96.92
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q3 2014
234 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q3 2014.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 204 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.6M shares
of 44.9M outstanding shares and own 85.96% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (5.13M shares), FMR LLC (3.19M shares), GILDER GAGNON HOWE & CO LLC (3.18M shares), JENNISON ASSOCIATES LLC (2.26M shares), VANGUARD GROUP INC (2.09M shares), MARSICO CAPITAL MANAGEMENT LLC (1.51M shares), BlackRock Fund Advisors (1.38M shares), State Street Corp (1.01M shares), JANUS CAPITAL MANAGEMENT LLC (1.01M shares), and BlackRock Institutional Trust Company, N.A. (934K shares).
This table shows the top 204 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.